Adis JournalsBrowse
Summary Slide.png (71.79 kB)
Download file

Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Diabetic Macular Edema Patients: Protocol for a Multicenter, Randomized Controlled, Open-Label Trial

Download (71.79 kB)
media
posted on 11.06.2020, 11:59 by Ryoichi Ishibashi, Yoko Takatsuna, Masaya Koshizaka, Tomoaki Tatsumi, Sho Takahashi, Kengo Nagashima, Noriko Asaumi, Miyuki Arai, Fumio Shimada, Kaori Tachibana, Yoshihiro Watanabe, Ko Ishikawa, Akiko Hoshino, Kyohei Yamamoto, Mariko Kubota-Taniai, Takafumi Mayama, Shuichi Yamamoto, Koutaro Yokote

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

References

Usage metrics

Read the peer-reviewed publication

Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Diabetic Macular Edema Patients: Protocol for a Multicenter, Randomized Controlled, Open-Label Trial
Diabetes TherapyDiabetes Therapy

Categories

Keywords

Anti-vascular endothelial growth factor agentCentral retinal thicknessDiabetic macular edemaGlucose co-transporter 2 inhibitorOptical coherence tomography

Licence

CC BY-NC 4.0

Exports